Difference between revisions of "Plicamycin (Mithracin)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 10: Line 10:
  
 
==Diseases for which it was used==
 
==Diseases for which it was used==
*[[Chronic myelogenous leukemia]]
+
*[[Chronic myelogenous leukemia - historical|Chronic myelogenous leukemia]]
*[[Testicular cancer]]
+
*[[Testicular cancer - historical|Testicular cancer]]
  
 
==Also known as==
 
==Also known as==
Line 26: Line 26:
 
[[Category:Human DNA synthesis inhibitors]]
 
[[Category:Human DNA synthesis inhibitors]]
  
[[Category:Testicular cancer medications]]
+
[[Category:Chronic myelogenous leukemia medications (historic)]]
 +
[[Category:Testicular cancer medications (historic)]]
 
[[Category:FDA approved in 1970]]
 
[[Category:FDA approved in 1970]]
 
[[Category:Discontinued drugs]]
 
[[Category:Discontinued drugs]]

Revision as of 00:32, 29 April 2022

General information

Class/mechanism: Antibiotic oncologic, intercalates DNA base pairs, and inhibits DNA and RNA synthesis. Has been used for hypercalcemia; lowers serum calcium levels independent of cytotoxic activity by blocking parathyroid hormone action on osteoclasts.[1][2]
Route: IV
Extravasation: irritant/vesicant

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

Diseases for which it was used

Also known as

  • Generic name: mithramycin
  • Brand name: Mithracin

References